Be your own advocate: Morgan England, stage III melanoma survivor, shares her story
As a Stage III Melanoma survivor, Morgan speaks on how important it is to be your own advocate. After her diagnosis, she requested the DecisionDx-Melanoma test from her doctor for the additional information it can provide. The results she received from her DecisionDx-Melanoma test report continue to help reduce her anxiety and provide confidence about her future.
With DecisionDx-Melanoma, you and your doctor can make informed decisions about:
Hear how physicians use DecisionDx-Melanoma
Aaron Farberg, MD describes how DecisionDx-Melanoma provides value for his patients
Why DecisionDx-Melanoma?
The only prognostic test to be associated with improved patient survival4 and covered by Medicare.
Talk to your doctor to determine if the DecisionDx-Melanoma test is right for you.
References
- Berger et al. CMRO. 2016.
- Farberg et al. J Drugs Derm. 2017.
- Dillon et al. CMRO. 2022.
- Bailey et al. JCO PO. 2023.
- Dhillon et al. Arch Dermatol Res. 2023.